Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T24466 |
Milademetan free base
DS3032B,DS-3032,DS3032,DS 3032,DS 3032B,DS-3032B |
Others | Others |
Milademetan (DS-3032b or DS-3032) is a potent and selective MDM2 inhibitor with potential antineoplastic activity. Milademetan (p.o.) binds to and prevents the binding of MDM2 protein to the transcriptional activation domain of the tumor suppressor protei | |||
T12040 |
Milademetan
RAIN-32,DS-3032,DS3032b |
Mdm2; Others | Apoptosis; Others |
Milademetan (DS-3032) 是一种具有口服活性和有效性的 MDM2 抑制剂,具有抗肿瘤活性,诱导 G1 细胞周期阻滞、衰老和凋亡。Milademetan 可用于研究急性髓系白血病和实体肿瘤。 | |||
T28038 |
Milademetan HCl (1398568-47-2 free base)
Milademetan HCl,DS3032,DS 3032,DS-3032,DS3032b,DS-3032b,DS 3032b |
Others | Others |
Milademetan is a potent and selective MDM2 inhibitor. MDM2 inhibitor DS-3032b binds to and prevents the binding of MDM2 protein to the transcriptional activation domain of the tumor suppressor protein p53 upon oral administration. By preventing this MDM2-p53 interaction, the proteosome-mediated enzymatic degradation of p53 is inhibited and the transcriptional activity of p53 is restored. This results in the restoration of p53 signaling and leads to the p53-mediated induction of tumor cell apopto... |